Alexandria Real Estate Equities
ARE
$124.17
Share price
0.09%
Change (1 day)
6.21%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - Net assets
Net assets on the balance sheet as of March 2024 : $22.75 B
According to Alexandria Real Estate Equities
's latest financial reports the company has $22.75 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Alexandria Real Estate Equities - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $22.62 B | -0.27% |
| 2022-12-31 | $22.68 B | 19.18% |
| 2021-12-31 | $19.03 B | 41.58% |
| 2020-12-31 | $13.44 B | 32.24% |
| 2019-12-31 | $10.16 B | 28.78% |
| 2018-12-31 | $7.89 B | 21.77% |
| 2017-12-31 | $6.48 B | 20.45% |
| 2016-12-31 | $5.38 B | 25.35% |
| 2015-12-31 | $4.29 B | 9.83% |
| 2014-12-31 | $3.90 B | -1.74% |
| 2013-12-31 | $3.97 B | 13.58% |
| 2012-12-31 | $3.50 B | 2.04% |
| 2011-12-31 | $3.43 B | 14.95% |
| 2010-12-31 | $2.98 B | 24.12% |
| 2009-12-31 | $2.40 B | 38.19% |
| 2008-12-31 | $1.74 B | 15.78% |
| 2007-12-31 | $1.50 B | 6.72% |
| 2006-12-31 | $1.40 B | 65.8% |
| 2005-12-31 | $0.84 B | 36.98% |
| 2004-12-31 | $0.62 B | 22.35% |
| 2003-12-31 | $0.50 B | 4.38% |
| 2002-12-31 | $0.48 B | 46.06% |
| 2001-12-31 | $0.33 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 292.37% | 🇺🇸 USA |
 Eli Lilly LLY | $12.89 B | -43.32% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | -72.61% | 🇺🇸 USA |
 Gilead Sciences GILD | $22.74 B | -0.03% | 🇺🇸 USA |
 Illumina ILMN | $5.74 B | -74.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | -27.28% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.22 B | -100.96% | 🇺🇸 USA |